Showing 1 to 3 of 3 results


Essure Birth Control Device Faces 27,000 Complaints, FDA Scrutiny
The Essure permanent birth control device, despite FDA approval, has prompted nearly 27,000 complaints since 2002 due to reported severe side effects like pain and organ perforation, leading to sales restrictions, a black box warning, and a mandated FDA post-market trial concluding in 2023.
Essure Birth Control Device Faces 27,000 Complaints, FDA Scrutiny
The Essure permanent birth control device, despite FDA approval, has prompted nearly 27,000 complaints since 2002 due to reported severe side effects like pain and organ perforation, leading to sales restrictions, a black box warning, and a mandated FDA post-market trial concluding in 2023.
Progress
60% Bias Score


Philips Respironics Faces Massive Lawsuit
Millions of patients affected by Philips Respironics' defective respiratory devices are pursuing compensation through a class-action lawsuit, but Philips is fighting back.
Philips Respironics Faces Massive Lawsuit
Millions of patients affected by Philips Respironics' defective respiratory devices are pursuing compensation through a class-action lawsuit, but Philips is fighting back.
Progress
0% Bias Score

DOD Revokes $6.7 Million Grant for Infant Heart-Defect Device
Cornell University professor James Antaki's $6.7 million grant for his infant heart-defect device, PediaFlow, was unexpectedly revoked by the Department of Defense on April 8th, jeopardizing three decades of research and potentially delaying a life-saving technology.

DOD Revokes $6.7 Million Grant for Infant Heart-Defect Device
Cornell University professor James Antaki's $6.7 million grant for his infant heart-defect device, PediaFlow, was unexpectedly revoked by the Department of Defense on April 8th, jeopardizing three decades of research and potentially delaying a life-saving technology.
Progress
64% Bias Score
Showing 1 to 3 of 3 results